SFI
GBIO

Susquehanna Fundamental Investments’s Generation Bio GBIO Stock Holding History

Susquehanna Fundamental Investments’s Portfolio GBIO Stock Details GBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,950
Closed -$525K – 1763
2021
Q2 		$525K Hold
1,950
– – 0.01% 1144
2021
Q1 		$555K Hold
1,950
– – 0.01% 1116
2020
Q4 		$553K Hold
1,950
– – 0.01% 1064
2020
Q3 		$603K Buy
+1,950
New +$466K 0.02% 819

Other funds holding GBIO

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
YCM
Yiheng Capital Management San Francisco, California $231M AUM 29.07% 1-Year Est. Return

Susquehanna Fundamental Investments's GBIO Position: Q3 2021 in Review

Susquehanna Fundamental Investments sold out of Generation Bio (GBIO) in Q3 2021, closing a stake of 1,950 shares — an estimated $525K sold.

Susquehanna Fundamental Investments first reported a position in GBIO in Q3 2020 and held it in 4 quarters. The position peaked at $603K in Q3 2020. 81 funds tracked by Wall St. Rank hold GBIO as of Q3 2021.

  • Susquehanna Fundamental Investments reported no remaining Generation Bio position as of Q3 2021 after selling out during the quarter.
  • Susquehanna Fundamental Investments sold 1,950 Generation Bio shares in Q3 2021, an estimated $525K.
  • Susquehanna Fundamental Investments first reported a position in Generation Bio in Q3 2020 and held it in 4 quarters.
  • Susquehanna Fundamental Investments's Generation Bio position peaked at $603K in Q3 2020.
  • 81 funds tracked by Wall St. Rank held Generation Bio as of Q3 2021.

Based on Susquehanna Fundamental Investments's 13F filing for Q3 2021, filed 15 Nov 2021.